How AI and robotics designed new cancer therapies

The latest episode of the DDW 'In Conversation With' series is available to listen to below. This week, Bruno Quinney speaks to Angus Sinclair, Chief Scientific Officer at LabGenius Therapeutics. LabGenius is a biotech using AI and robotics to design new cancer therapies, and in vivo efficacy data reveals the company's novel T-cell engager shows complete tumour elimination in mice. Bruno talks to Angus about what T-cell engagers actually are, how AI is driving the company's approach, and why non-intuitive protein design is emerging within immuno-oncology drug development. You can listen below, or find The Drug Discovery World Podcast on Spotify , Google Play and Apple Podcasts.

You can listen to How AI and robotics designed new cancer therapies online on Radio and Podcast. Open the player on this page to stream the available audio.

How AI and robotics designed new cancer therapies is an episode from The Drug Discovery World Podcast by Drug Discovery World.

This episode is 16:48 long.

This episode was published on Apr 23, 2026.

Yes. Use the heart button on the episode page to add it to your favorite episodes list.

Yes. This page shows related episodes from The Drug Discovery World Podcast when more episodes are available from the podcast feed.